Frenkel_2003_Vaccine_21_1060

Reference

Title : Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization - Frenkel_2003_Vaccine_21_1060
Author(s) : Frenkel D , Dewachter I , Van Leuven F , Solomon B
Ref : Vaccine , 21 :1060 , 2003
Abstract :

Antibodies to the epitope EFRH, representing residues 3-6 within the beta-amyloid (Abeta) sequence, were previously shown to affect the solubility and disaggregation of Abeta fibrils in vitro. Here, we describe a novel method of immunization, using as antigen the EFRH peptide displayed on the surface of the filamentous phage. The EFRH phage evoked effective auto-immune antibodies in amyloid precursor protein [V717I] (APP[V717I]) transgenic mice that recapitulate the amyloid plaques and vascular pathology of Alzheimer's disease (AD). The immunization provoked a considerable reduction in the number of Abeta amyloid plaques in the brain of the transgenic mice and may serve as the basis for anti-Abeta vaccine.

PubMedSearch : Frenkel_2003_Vaccine_21_1060
PubMedID: 12559780

Related information

Citations formats

Frenkel D, Dewachter I, Van Leuven F, Solomon B (2003)
Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization
Vaccine 21 :1060

Frenkel D, Dewachter I, Van Leuven F, Solomon B (2003)
Vaccine 21 :1060